Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors

被引：0
|
作者：
Chen Wei
Muhammad Fazal
Alexander Loh
Ridhima Kapoor
Sofia Elena Gomez
Shayena Shah
Albert J. Rogers
Sanjiv M. Narayan
Paul J. Wang
Ronald M. Witteles
Alexander C. Perino
Paul Cheng
June-Wha Rhee
Tina Baykaner
机构：
[1] Stanford University,Department of Internal Medicine
[2] Stanford University,Department of Cardiovascular Medicine
[3] Kaiser Permanente Santa Clara Homestead Medical Center,Department of Internal Medicine
[4] Stanford University,Stanford University School of Medicine
[5] City of Hope Comprehensive Medical Center,Division of Cardiology, Department of Medicine
来源：
Journal of Interventional Cardiac Electrophysiology | 2024年 / 67卷
关键词：
Cardio-oncology; Tyrosine kinase inhibitors; Ibrutinib; Arrhythmias; Atrial fibrillation; Tyrosine kinase inhibitors; Atrial arrhythmias; Ventricular arrhythmias;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：111 / 118
页数：7
相关论文
共 50 条
  • [21] Tyrosine kinase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (01) : 40 - 40
  • [22] Tyrosine Kinase Inhibitors
    Natoli, C.
    Perrucci, B.
    Perrotti, F.
    Falchi, L.
    Iacobelli, S.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (05) : 462 - 483
  • [23] Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors
    Skubitz, Keith M.
    ONCOLOGIST, 2019, 24 (07): : E600 - E602
  • [24] Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors
    Hakozaki, Taiki
    Matsuo, Takuma
    Shimizu, Akihiro
    Ishihara, Yoko
    Hosomi, Yukio
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) : 64 - 71
  • [25] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    Lee, P. M.
    Chang, C. T.
    Yusoff, Z. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 46 - 54
  • [26] Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital
    P. M. Lee
    C. T. Chang
    Z. M. Yusoff
    International Journal of Clinical Pharmacy, 2021, 43 : 46 - 54
  • [27] PERCEIVED COGNITIVE PROBLEMS AMONG CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
    Nelson, Ashley M.
    Hoogland, Aasha I.
    Hyland, Kelly A.
    Christy, Shannon M.
    Kennedy, Brittany
    Root, James C.
    Ahles, Tim
    Jacobsen, Paul
    Jim, Heather
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S22 - S22
  • [28] Risk of QTc interval prolongation among cancer patients treated with tyrosine kinase inhibitors.
    Abu Rmilah, Anan Abdelmoti
    Lin, Grace
    Herrmann, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors
    Veltmaat, Lukas
    Cortes, Jorge
    BLOOD, 2024, 143 (10) : 858 - 865
  • [30] COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) OF TYROSINE KINASE INHIBITORS
    NICKLAUS, MC
    BOLEN, JB
    LI, ZH
    BURKE, TR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 139 - MEDI
12345